Skip to main content
Sirnaomics Ltd. logo

Sirnaomics Ltd. — Investor Relations & Filings

Ticker · 2257 LEI · 2549004JEEDTBC6EHW37 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 402 across all filing types
Latest filing 2025-04-25 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 2257

About Sirnaomics Ltd.

http://www.sirnaomics.com

Sirnaomics Ltd. is a clinical-stage RNA therapeutics biopharmaceutical company focused on discovering and developing innovative drugs for indications with significant unmet medical needs. The company's pipeline addresses a broad spectrum of therapeutic areas, including oncology, fibrosis-related diseases, skin conditions, antiviral and cardiometabolic diseases, and medical aesthetics. Sirnaomics utilizes proprietary delivery platforms, which form the foundation of its RNA-based therapeutics. These platforms include the Polypeptide Nanoparticle (PNP) system for administering mRNA vaccines and therapeutics, and the GalNAc delivery platform for systemic administration of liver-targeting RNA interference (RNAi) therapeutics. The company is recognized as the first to achieve positive Phase IIb clinical outcomes in oncology using clinical-stage RNA therapeutics.

Recent filings

Filing Released Lang Actions
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND BUY BACK SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED RE-APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular containing the "Letter from the Board," detailed explanatory statements on share issue and buy-back mandates, re-election of directors, re-appointment of auditor, as well as the formal "Notice of Annual General Meeting" and the accompanying proxy form. It is clearly a proxy solicitation and information statement sent to shareholders to request votes at the upcoming AGM, rather than the AGM presentation materials themselves or a full annual report.
2025-04-25 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the formal Notice of Annual General Meeting of Sirnaomics Ltd., listing the date, time, location, proposed ordinary resolutions (including adoption of financial statements, re-election of directors, auditor appointment, share issuance and buy-back mandates), and detailed proxy appointment instructions. It is clearly a proxy solicitation/information statement for shareholders to vote, rather than the AGM materials/presentation themselves or a full annual report. Therefore, it fits the Proxy Solicitation & Information Statement category.
2025-04-25 English
CESSATION OF HONORARY SCIENTIFIC ADVISOR
Board/Management Information Classification · 1% confidence The document is an announcement under the Hong Kong Listing Rules regarding the cessation of an Honorary Scientific Advisor and related board positions. It details changes in senior management/board roles rather than financial results, legal proceedings, or report publication. This matches the definition for Board/Management Information (MANG).
2025-04-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Share Issue/Capital Change Classification · 1% confidence The document is a Form FF301 monthly return filed with the Hong Kong Stock Exchange (HKEX) under Chapter 19B of the Listing Rules, detailing movements in authorised share capital, issued shares, treasury shares, share options, convertibles, and RSU arrangements. This is not a simple announcement or summary but the actual regulatory return with numerical details about capital structure changes. It directly reports on share issue and capital changes rather than announcing a dividend, M&A, or earnings. Therefore the most appropriate classification is "Share Issue/Capital Change" (SHA).
2025-04-03 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Earnings Release Classification · 1% confidence The document is titled “ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024” and contains audited consolidated annual results, business and financial highlights, management discussion and analysis, and forward-looking strategic commentary. It is the standalone results announcement rather than a comprehensive Annual Report (which would include full financial statements with notes and auditor’s report) or a mere notice of publication. Therefore this corresponds to an Earnings Release (initial announcement of periodical financial results). FY 2024
2025-03-27 English
RESIGNATION OF NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 1% confidence The document is an announcement regarding the resignation of a non-executive director and related board changes. It clearly falls under ‘Board/Management Information’ which covers announcements of changes in the company’s board of directors or senior management.
2025-03-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.